[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Postmenopausal Vaginal Atrophy Treatment Market Data Survey Report 2025

October 2017 | 76 pages | ID: G4630D39341EN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.

The global Postmenopausal Vaginal Atrophy Treatment market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)

Average market price by SUK

MAJOR APPLICATIONS

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
  • Allergan
  • Pfizer
  • Shionogi
  • Novo Nordisk
  • Teva Pharmaceutical
  • Bayer.
MAJOR APPLICATIONS AS FOLLOWS:
  • Topical Estrogen
  • Systemic Estrogen
  • Non-hormonal Therapy
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.4 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Allergan
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Pfizer
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Shionogi
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Novo Nordisk
  3.4.1 Company Information
  3.4.2 Product Specifications
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Teva Pharmaceutical
  3.5.1 Company Information
  3.5.2 Product Specifications
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Bayer.
  3.6.1 Company Information
  3.6.2 Product Specifications
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 MAJOR APPLICATION

4.1 Topical Estrogen
  4.1.1 Overview
  4.1.2 Topical Estrogen Market Size and Forecast
4.2 Systemic Estrogen
  4.2.1 Overview
  4.2.2 Systemic Estrogen Market Size and Forecast
4.3 Non-hormonal Therapy
  4.3.1 Overview
  4.3.2 Non-hormonal Therapy Market Size and Forecast

5 MARKET PRICE

5.1 Overview
5.2 Price by SUK

6 CONCLUSION

LIST OF TABLES

Tab Regional Production 2011-2017 (Value)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Allergan
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of Shionogi
Tab Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of Bayer.
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)

LIST OF FIGURES

Fig Global Postmenopausal Vaginal Atrophy Treatment Market Size and CAGR 2011-2017 (Value)
Fig Global Postmenopausal Vaginal Atrophy Treatment Market Size and CAGR 2011-2017 (Volume)
Fig Global Postmenopausal Vaginal Atrophy Treatment Market Forecast and CAGR 2018-2025 (Value)
Fig Global Postmenopausal Vaginal Atrophy Treatment Market Forecast and CAGR 2018-2025 (Volume)
Fig Topical Estrogen Market Size and CAGR 2011-2017 (Value)
Fig Topical Estrogen Market Size and CAGR 2011-2017 (Volume)
Fig Topical Estrogen Market Forecast and CAGR 2018-2025 (Value)
Fig Topical Estrogen Market Forecast and CAGR 2018-2025 (Volume)
Fig Systemic Estrogen Market Size and CAGR 2011-2017 (Value)
Fig Systemic Estrogen Market Size and CAGR 2011-2017 (Volume)
Fig Systemic Estrogen Market Forecast and CAGR 2018-2025 (Value)
Fig Systemic Estrogen Market Forecast and CAGR 2018-2025 (Volume)
Fig Non-hormonal Therapy Market Size and CAGR 2011-2017 (Value)
Fig Non-hormonal Therapy Market Size and CAGR 2011-2017 (Volume)
Fig Non-hormonal Therapy Market Forecast and CAGR 2018-2025 (Value)
Fig Non-hormonal Therapy Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025


More Publications